Diphenyl diselenide protects against diabetic kidney disease through modulating gut microbiota dysbiosis in streptozotocin-induced diabetic rats

• 主要な著者: Xing Wang (著者), Dongmei Long (著者), Xingcan Peng (著者), Jiaxuan Li (著者), Maoting Zhou (著者), Yu Wang (著者), Xianghong Hu (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2024-12-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

IntroductionDiphenyl diselenide (DPDS) ameliorates nephropathy in streptozotocin (STZ)-induced type 1 diabetic rats by inhibiting oxidative stress and inflammatory reactions. However, it has not been clarified whether DPDS alleviates type 1 diabetic kidney disease (DKD) is related to the inhibition...